Subject(s)
Atherosclerosis/genetics , Atherosclerosis/metabolism , Lipid Metabolism/genetics , R-Loop Structures/genetics , Scavenger Receptors, Class A/genetics , Spike Glycoprotein, Coronavirus/genetics , Humans , Macrophages/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Scavenger Receptors, Class A/metabolism , Spike Glycoprotein, Coronavirus/metabolismABSTRACT
In the face of the sudden outbreak of new type of coronavirus, the virus is spreading at a faster rate than expected, which seriously threatens people’s life and health and national security. According to the World Organization, infectious diseases have been at a high incidence in the last two decades. How to transport kits and vaccines safely and efficiently to suspected cases and patients in a short period of time is related to the speed of national control of the epidemic. This paper first analyzes the scale of the pharmaceutical cold chain market in China, analyzes the policy of the pharmaceutical cold chain industry issued by the state, and analyzes the problems existing in the pharmaceutical cold chain industry;then it analyzes the influence of epidemic situation on cold chain transportation, and finally puts forward the safe and efficient transportation scheme of vaccine under epidemic situation.